Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of the Anticancer Potentials of the Free and Metal-Organic Framework (UiO-66) - Delivered Phycocyanobilin. | J Pharm Sci | 2023 | 36087776 | PubTator, text mining | PubMed |
| The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. | Cell Biol Toxicol | 2023 | 35953652 | PubTator, text mining | PubMed |
| The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia. | Blood Adv | 2023 | 35358998 | PubTator, text mining | PubMed |
| Cancer insights from magnetic resonance spectroscopy of cells and excised tumors. | NMR Biomed | 2023 | 35262263 | PubTator, text mining | PubMed |
| Noncoding RNAs in apoptosis: identification and function. | Turk J Biol | 2022 | 37533667 | PubTator, text mining | PubMed |
| Gastrulation and Body Axes Formation: A Molecular Concept and Its Clinical Correlates. | Malays J Med Sci | 2022 | 36818899 | PubTator, text mining | PubMed |
| Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. | Front Genet | 2022 | 36685962 | PubTator, text mining | PubMed |
| Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma. | Front Genet | 2022 | 36685912 | PubTator, text mining | PubMed |
| Bioinformatic analysis and machine learning to identify the diagnostic biomarkers and immune infiltration in adenomyosis. | Front Genet | 2022 | 36685847 | PubTator, text mining | PubMed |
| Long non-coding RNA CNALPTC1 promotes gastric cancer progression by regulating the miR-6788-5p/PAK1 pathway. | J Gastrointest Oncol | 2022 | 36636079 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer. | Int J Mol Sci | 2022 | 36613528 | PubTator, text mining | PubMed |
| Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells. | Cancers (Basel) | 2022 | 36612206 | PubTator, text mining | PubMed |
| Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers. | Front Cell Dev Biol | 2022 | 36589746 | PubTator, text mining | PubMed |
| A novel lnc-LAMC2-1:1 SNP promotes colon adenocarcinoma progression by targeting miR-216a-3p/HMGB3. | Heliyon | 2022 | 36582685 | PubTator, text mining | PubMed |
| A Prediction Model for Rapid Identification of Ischemic Stroke: Application of Serum Soluble Corin. | J Multidiscip Healthc | 2022 | 36582588 | PubTator, text mining | PubMed |
| Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. | World J Gastroenterol | 2022 | 36569275 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
| RKIP: A Pivotal Gene Product in the Pathogenesis of Cancer. | Cancers (Basel) | 2022 | 36551578 | PubTator, text mining | PubMed |
| The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma. | Front Oncol | 2022 | 36544710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=14